Medical anti-corruption A number of hospital chiefs were investigated.

Recently, the local disciplinary commission disclosed that many of the cases are related to medical anti-corruption.
so far in September alone, six hospital chiefs have been investigated for medical corruption, according to Seber blue incomplete statistics.
September 22, Guang'an Municipal Commission for Discipline Inspection officials micro-release news that Yuechi County Luodu Center Health Hospital Director Lei Jianqiang suspected of serious disciplinary violations, is currently under disciplinary review and supervision investigation.
September 21, according to the Aba County Commission for Discipline Inspection official micro-news, Lutang County Health Bureau Party Committee member, county People's Hospital President Luo Fangyong suspected of serious disciplinary violations, by the Aba County Commission for Discipline Inspection designated jurisdiction, Xiaojin County Commission for Discipline Inspection is conducting its disciplinary review and supervision investigation.
September 18, according to the Central Commission for Discipline Inspection and Supervision of the State Supervision Committee in the Ministry of Transport, Hebei Provincial Commission for Discipline Inspection and Supervision news: Civil Aviation Administration Civil Aviation Medical Center (Civil Aviation General Hospital) of the former deputy secretary of the Party Committee, director (president) Li Songlin suspected of serious disciplinary violations, is currently receiving the Central Commission for Discipline Inspection in the Ministry of Transport discipline inspection team disciplinary review and hebei Province, Yantai City Commission for Discipline Inspection supervision and investigation.
September 17, according to the Tibet Autonomous Region Commission for Discipline Inspection, the party secretary and vice-president of the Second People's Hospital of the Tibet Autonomous Region, Li Bin, suspected of serious disciplinary violations, has turned himself in and is currently under disciplinary review and supervision investigation by the Commission for Discipline Inspection of the Autonomous Region.
September 6, Luxuan County People's Hospital Party Committee Deputy Secretary, President Li Tao suspected of serious disciplinary violations, the initiative to throw in the case, by the Zhoukou Municipal Commission for Discipline Inspection designated jurisdiction, is currently under the Sichuan Hui District Commission for Discipline Inspection disciplinary review and supervision investigation.
September 2, the Sichuan Provincial Commission for Discipline Inspection issued the authority: Sichuan Aba County People's Hospital President Gu Yunxuan suspected of serious disciplinary violations, is currently under disciplinary review and supervision investigation.
from the cases that have been disclosed so far, we can see that the state's efforts to combat drug corruption are indeed growing.
crack down on drug corruption, 19 provinces on-the-ground inspection of the top-level design is promoting the fight against commercial bribery of medicine.
Recently, the General Supervision Department of the National Health and Safety Commission issued a notice that the National Health and Safety Commission is scheduled to work with relevant departments in late September to organize comprehensive supervision and supervision of the medical and health industry, Beijing, Hebei and other 19 provinces (regions, cities) and Xinjiang Production and Construction Corps on-site inspection.
The National Health and Safety Commission made it clear that the focus of the inspectors will be around the medical and health industry comprehensive supervision system to promote the implementation of the situation and the prevention and control of the outbreak of neo-crown pneumonia, through the National Health and Health Commission complaints to report telephone and mailbox collection clues.
The main collection of commercial bribery in the field of medicine and other unfair competition, medical institutions illegal practice, illegal publication of medical advertising, medical insurance fixed-point medical institutions do not regulate the use of medical insurance funds, public medical institutions have not implemented collection and cancellation of the increase, medical and health industry institutions and related personnel illegal promotion of infant and young children-related food and other issues clues.
, the inspection team will conduct spot checks and verifications during field inspections to respond to social and public concerns in a timely manner.
: 18 September to 31 October 2020.
Reporting Telephone: 010-84088534 (fax) E-mail: ylwshyzhjgdc@163.com In addition, the State Health Insurance Administration recently announced that in order to increase the crackdown on commercial bribery in medicine, the State Health Insurance Administration and the Supreme People's Court recently signed a memorandum of understanding, will establish a regular notification system of commercial bribery cases in the field of medicine, expand the use of judicial results in the field of commercial bribery in the field of pharmaceutical prices and recruitment, and jointly promote information exchange and sharing at all levels of the system.
During the same period, the State Health Insurance Administration also issued the Guidance on the Establishment of a Credit Evaluation System for Pharmaceutical Prices and Recruitment, which was used to promote the improvement of the market-led mechanism for the formation of pharmaceutical prices, and requested all localities to establish and implement a credit evaluation system for pharmaceutical prices and recruitment by the end of 2020.
look further ahead, since the second half of this year, the state regulatory authorities are indeed frequently issued on the field of pharmaceutical purchase and sale of anti-corruption documents.
July 24, the General Office of the National Health and Safety Commission issued a Notice on the Issue of a Special Action Plan for the Construction of The Style of the Medical Industry in 2020, which mentioned that it would crack down on the illegality of collecting kickbacks from medical institutions.
July 23, the General Office of the State Council issued the Key Tasks for Deepening the Reform of the Medical and Health System in the Second Half of 2020, which mentions the need to improve the mechanism of comprehensive supervision and supervision of the medical and health industry, and to carry out the pilot work of "Credit plus Comprehensive Supervision".
On June 5, the National Health and Health Commission, the Ministry of Industry and Information Technology, the Ministry of Public Security and other nine departments jointly issued the "2020 correction of the field of pharmaceutical purchase and sale and medical services in the field of the wrong wind work points", clearly for the pharmaceutical purchase and sale of the field and medical services to draw a clear red line of behavior, the formation of a clean air of the industry.
including serious investigation and prosecution of the collection of pharmaceutical supplies enterprise rebate behavior.
On the issue of medical corruption, before the Central Commission for Discipline Inspection and Supervision of the State Health Commission discipline inspection and supervision group responsible for publicly said that will increase pressure transmission, in accordance with the "who is in charge, who is responsible" and "the management industry must manage the wind" requirements, around the medical and health sector outstanding issues, in-depth special rectification.
medical representatives, the dilemma is that the prosecution case officers have told the media that the medical and health sector corruption and bribery crimes involving many departments, many personnel.
Up to the Secretary, the President, down to the Chief of the Pharmacy Section, the Chief of the Finance Section, the purchaser, medical personnel, often investigate and deal with the case led out a number of cases, seized a person led several people or even dozens of people, forming a string of cases.
corruption often means that the hospital has "rotten" from top to bottom.
it can be seen that in kickbacks, medical corruption, is not a single individual problem, once deeply investigated, from the hospital to the dean, to the doctor, to the pharmaceutical companies, to the drug generation, may be identified the problem.
are increasingly in dilemma for the critical existence of the chain of relationships between pharmaceutical companies and hospitals.
medical representatives say one of the things they've had to do every day lately is open their mailboxes to see if there's any layoff emails from the company.
years, the core purpose of the work of pharmaceutical representatives has been to have doctors write their own medicines on prescription lists.
but with the increase of medical anti-corruption efforts, medical representatives want to see doctors are a problem, "medical representatives to lose their jobs" will often become a hot topic of public opinion.
In the past two years, in a series of systems, such as dynamic adjustment of medical insurance catalogue, price negotiation, centralized volume procurement, credit evaluation system of pharmaceutical companies, the operational profit space of pharmaceutical enterprises is getting smaller and smaller, and the living space of pharmaceutical representatives is getting smaller and smaller.
According to industry insiders, chengdu Fifth People's Hospital recently held two meetings, one is the supplier work interview, hospital staff, suppliers and agents of tender agencies representatives a total of more than 100 people attended the meeting;
, vice-president, director of the pharmacy department and other relevant departments and all pharmaceutical distribution enterprises in charge of a total of about 80 people attended the meeting.
hospital requires all medical representatives who carry out professional activities in the hospital to fill out and report the "Pharmaceutical Representative Filing Information Form" by September 21, 2020 to complete the relevant information filing.
information sheet mainly includes the representative's name, gender, photo, document number, education, profession, type of employment and other basic information, contract start date/termination date, authorized promotion of drug categories and therapeutic areas and other details related to the promotion of the representative.
that the company representing the company in which they work is fully responsible for the authenticity and accuracy of the information form.
the information form, attach the credit history of the medical representative.
The pharmaceutical business enterprise shall not have more than 2 pharmaceutical representatives for the record, the pharmaceutical production enterprise shall not exceed 1 person for the record of each variety, and the person who has not completed the record within the prescribed time shall not carry out relevant business activities in the hospital, and all units shall be invited to attach great importance to the consequences of overdue.
is the current high-pressure status quo in the industry, so that even compliant pharmaceutical representatives, but also deeply feel the difficulty of the profession.
medical representatives who used to mix like fish in hospitals now have to be careful.
recent times, the industry from time to time out of the hospital to inform medical representatives not to go to the hospital, medical representatives were taken away, and even about the drug was suspended news.
There are pharmaceutical representatives said that in the volume of procurement, medical anti-corruption, the future through a variety of non-compliant forms to do the market situation will be less and less, pharmaceutical representatives have no opportunity, no channels, no courage, no funds to do those jobs.
We can also see that with the promotion of national procurement, the pharmaceutical industry tax verification, as well as the two-vote system, health insurance fee control policy, coupled with a strict investigation of drug rebates, strict fight against medical corruption, the past rely on high drug pricing, channel space to drive sales of traditional drug marketing methods will be completely subverted, pharmaceutical companies must be timely transformation.
in the process of restructuring the entire industry, pharmaceutical representatives are also in urgent need of transformation.
only by compliance can we go further on the career path.
.